Showing 2021-2030 of 7169 results for "".
Improving the After-Sun Treatment Market
https://practicaldermatology.com/series/c-suite-chats/improving-after-sun-treatment-market/29805/Ed Esquenazi, PhD, Founder and CEO of health and performance company, Terns, discusses the after-sun treatment market and two new products designed to combat inflammation and aging after exposure to the sun.Growth Potential of the Aesthetic Market
https://practicaldermatology.com/series/c-suite-chats/growth-potential-of-the-aesthetic-market/29746/Merz Aesthetics President, North America, Patrick Urban discusses why he expects demand for aesthetic treatments to continue increasing and how to capitalize on it.SDPA: Andrew Mastro on Advancing Career By Building Yearly Goals
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-andrew-mastro-on-advancing-career-by-building-yearly-goals/29512/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Andrew Mastro, PA-C. Each year, Mastro leaves SDPA with a yearly goal in mind. He breaks down how SDPA contributes to the goal and what he does to achieve it.Pearls for Treating Atopic Skin
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-treating-atopic-skin/29483/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with dermatologist James Del Rosso, DO, about different ways to treat patients with atopic dermatitis (AD), including using a well-made moisturizers, and also exploring both the science and the use of newer topical agents. ThisASDS: Dr. Green on the Annual Meeting
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-green-annual-meeting/29169/Lawrence Green, MD, FAAD, talks about the education and networking that make the American Society for Dermatologic Surgery Annual Meeting special.PASI-HD: New Method for Measuring Severity in Mild to Moderate Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/pasi-hd-new-method-for-measuring-severity-in-mild-to-moderate-plaque-psoriasis/20185/Robert Higham, MPAS, PA-C, Executive Director of Clinical Development of Arcutis Biotherapeutics, discusses PASI-HD, a new measure designed to assess severity and therapeutic response in patients with mild and moderate psoriasis. PASI High Discrimination (PASI-HD) was developed to better understandMeaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
https://practicaldermatology.com/topics/psoriasis/meaningful-innovation-in-medical-dermatology-at-arcutis-biotherapeutics/20099/Frank Watanabe, President and CEO of Arcutis Biotherapeutics, shares what “meaningful innovation” means to Arcutis and how the company aims to create meaningful change for people living with chronic skin conditions.Sensus Healthcare: What's Next
https://practicaldermatology.com/topics/skin-cancer-photoprotection/sensus-healthcare-whats-next/19947/Along with other healthcare companies, Sensus faced challenges in 2020 as the COVID-19 pandemic emerged. But CEO Joe Sardano says the company is poised for success in 2021 and beyond. He discusses efforts to optimize physician reimbursement and strategies to expand access for patients.Almost There: Toward Systemic Therapy for AD in Children
https://practicaldermatology.com/topics/atopic-dermatitis/almost-there-toward-systemic-therapy-for-ad-in-children/19934/With the approval of the first biologic for management of atopic dermatitis, a new era is underway, says Amy Paller, MD. She addresses the role of dupilumab in practice and provides a look ahead at other agents in the pipeline for adolescent and pediatric patients.Grub Flubs: The Foods That Can Hurt the Skin
https://practicaldermatology.com/topics/general-topics/grub-flubs-the-foods-that-can-hurt-the-skin/19539/There's no doubt diet affects skin, says Rajani Katta, MD. She explains which foods can benefit the skin and which can have a detrimental effect. Hint: Sugar isn't so sweet.